Opus Genetics, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of unmet needs of patients with refractive and retinal eye disorders. The company offers Phentolamine Ophthalmic Solution for reversal of mydriasis, as well as is in Phase III clinical trials for presbyopia and dim light or night vision disturbances. Its lead retinal product candidate is APX3330, a small-molecule inhibitor of reduction oxidation effector factor-1 protein that has completed Phase II clinical trial for the treatment of diabetic retinopathy. The company also develops APX2009 and APX2014 that are preclinical product candidates for retina indications. The company was formerly known as Ocuphire Pharma, Inc. Opus Genetics, Inc. was founded in 2018 and is headquartered in Farmington Hills, Michigan.

Opus Genetics Inc.

In a report released yesterday, from National Bank maintained a Buy rating on Bird Construction, with a price target of C$72.00. In a report releas...

National Bank Remains a Buy on Bird Construction (BDT)

After SpaceX’s ($SPCX) high-profile IPO last month, investors are looking for ways to get exposure to the company’s fast growth in launch services,...

Looking for Exposure to SpaceX Stock (SPCX)? Consider These Two ETFs

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Forte Biosciences (FBRX), Sarepta Therapeutics (SRPT...

Analysts Offer Insights on Healthcare Companies: Forte Biosciences (FBRX), Sarepta Therapeutics (SRPT) and Opus Genetics (IRD)

SpaceX ($SPCX) stock is rising today, and there are a couple of reasons why. To begin with, the aerospace company just hit two major milestones tha...

SpaceX (SPCX) Stock Rallies after Firm Hits Major Launch Milestones

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Tenet Healthcare (THC) and Opus Genetics (IRD) with ...

Analysts Are Bullish on Top Healthcare Stocks: Tenet Healthcare (THC), Opus Genetics (IRD)

Iridium Communications ( ($IRDM) ) just unveiled an update. On July 2, 2026, Iridium completed its acquisition of the remaining 61% stake in Aireon...

Iridium Plans Rocket Lab Merger, Boosts Executive Retention

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on CVRx (CVRX), Opus Genetics (IRD) and Lifecore Biomed...

Analysts Are Bullish on These Healthcare Stocks: CVRx (CVRX), Opus Genetics (IRD)

Analysts are intrested in these 5 stocks: ( ($BHVN) ), ( ($QNCX) ), ( ($IRDM) ), ( ($EJTTF) ) and ( ($LOGI) ). Here is a breakdown of their recent


Biohaven, Quince, Iridium, EasyJet, Logitech Trending by Analysts

Opus Genetics, Inc. ($IRD) announced an update on their ongoing clinical study. Opus Genetics, Inc. is launching a Phase 1b/2a study called “A Phas...

Opus Genetics Advances New Gene Therapy Trial for Rare Childhood Blindness

Allbirds ( ($BIRD) ) has issued an announcement. On June 27, 2026, Smartbird, Inc. announced that board member Ravi Thanawala notified the company ...

Allbirds announces board transition as director departs

In a report released yesterday, Richard Nguyen from Bernstein reiterated a Buy rating on Viridien, with a price target of €130.00. The company’s sh...

Bernstein Remains a Buy on Viridien (0RI9)

Rocket Lab ($RKLB) stock gained over 3% on Tuesday as analysts continued to praise its plan to buy Iridium Communications ($IRDM). The latest lift ...

Rocket Lab Stock (RKLB) Surges as Top BofA Analyst Cheers Iridium Deal

Blackbird PLC ( ($GB:BIRD) ) just unveiled an announcement. Blackbird plc, listed on AIM as BIRD, develops and licenses cloud-native video editing ...

Blackbird plc reports unchanged share option block amid stable issuance

Companies in the Communication Services sector have received a lot of coverage today as analysts weigh in on Trade Desk (TTD) and Iridium Communica...

Analysts Offer Insights on Communication Services Companies: Trade Desk (TTD) and Iridium Communications (IRDM)

Rocket Lab’s ($RKLB) planned $8 billion acquisition of Iridium ($IRDM) fundamentally changes the rocket company’s financial profile by adding a pro...

Rocket Lab’s (RKLB) Iridium Acquisition Adds the Cash Flow It Was Missing

Shares in Rocket Lab ($RKLB), a custom satellite and spacecraft component manufacturer, climbed about 16% on Monday. This followed the company’s $8...

Why Rocket Lab’s (RKLB) $8B Iridium Deal Is Not a Shot at SpaceX (SPCX)

JonesTrading analyst Debanjana Chatterjee reiterated a Buy rating on Opus Genetics today and set a price target of $10.00. Chatterjee covers the He...

JonesTrading Sticks to Their Buy Rating for Opus Genetics (IRD)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Opus Genetics (IRD) and Establishment Labs Holdings ...

Analysts Offer Insights on Healthcare Companies: Opus Genetics (IRD) and Establishment Labs Holdings (ESTA)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Establishment Labs Holdings (ESTA) and Opus Genetics...

Analysts Offer Insights on Healthcare Companies: Establishment Labs Holdings (ESTA) and Opus Genetics (IRD)

The company has pivoted to AI infrastructure. 


	A	B	C	D
1	Symbol	Price	Change	Volume
2	IRD	$3.27	-0.30%	506.28K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	IRD	$3.27	-0.3%	506.28K
3
4
5
6

IRD

IRD

Get Opus Genetics Inc. Data in Excel

Get Opus Genetics Inc. Data in Excel